DERMA SCIENCES INC's ticker is DSCI and the CUSIP is 249827502. A total of 53 filers reported holding DERMA SCIENCES INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $128,000 | +100.0% | 24,514 | +78.8% | 0.00% | – |
| Q3 2016 | $64,000 | +700.0% | 13,708 | +571.0% | 0.00% | – |
| Q2 2016 | $8,000 | -65.2% | 2,043 | -72.2% | 0.00% | – |
| Q1 2016 | $23,000 | -58.2% | 7,352 | -37.9% | 0.00% | – |
| Q4 2015 | $55,000 | -33.7% | 11,837 | -32.9% | 0.00% | – |
| Q3 2015 | $83,000 | -48.4% | 17,649 | -21.5% | 0.00% | – |
| Q2 2015 | $161,000 | +78.9% | 22,490 | +111.7% | 0.00% | – |
| Q1 2015 | $90,000 | -4.3% | 10,625 | +4.5% | 0.00% | – |
| Q4 2014 | $94,000 | -35.6% | 10,170 | -41.7% | 0.00% | – |
| Q3 2014 | $146,000 | -1.4% | 17,447 | +35.5% | 0.00% | – |
| Q2 2014 | $148,000 | +23.3% | 12,877 | +36.4% | 0.00% | – |
| Q1 2014 | $120,000 | +757.1% | 9,441 | +655.9% | 0.00% | – |
| Q4 2013 | $14,000 | – | 1,249 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 507,799 | $1,574,000 | 1.86% |
| Krensavage Asset Management, LLC | 906,046 | $2,809,000 | 1.01% |
| DAFNA Capital Management LLC | 353,718 | $1,097,000 | 0.95% |
| Broadfin Capital, LLC | 2,562,104 | $7,943,000 | 0.77% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 124,549 | $386,000 | 0.18% |
| Senvest Management, LLC | 489,807 | $1,518,000 | 0.13% |
| Baker Brothers Advisors | 3,752,390 | $11,632,000 | 0.12% |
| Perceptive Advisors | 432,884 | $1,341,000 | 0.12% |
| Granahan Investment Management | 1,028,460 | $3,188,000 | 0.12% |
| Alambic Investment Management, L.P. | 49,035 | $152,000 | 0.05% |